UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Myriad Genetics
MYGN
$315M
| $1.05M | ﹤0.01% |
72,212
-2,546
| -3% | -$47.4K |
|
1777
PROG Holdings
PRG
$1.69B
| $1.05M | ﹤0.01% |
62,021
+1,120
| +2% | +$19.1K |
|
1778
Ethan Allen Interiors
ETD
$600M
| $1.05M | ﹤0.01% |
39,646
+1,033
| +3% | +$26.7K |
|
1779
Rocket Pharmaceuticals
RCKT
$393M
| $1.05M | ﹤0.01% |
53,471
+14,333
| +37% | +$264K |
|
1780
GeoPark
GPRK
$628M
| $1.05M | ﹤0.01% |
67,715
+16,800
| +33% | +$239K |
|
1781
ZipRecruiter
ZIP
$409M
| $1.05M | ﹤0.01% |
63,693
-2,641
| -4% | -$43.8K |
|
|
PAYA
1782
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $1.04M | ﹤0.01% |
132,723
+13,529
| +11% | +$104K |
|
|
RDUS
1783
DELISTED
Radius Recycling
RDUS
| $1.04M | ﹤0.01% |
34,054
+674
| +2% | +$20.8K |
|
1784
Community Health Systems
CYH
$412M
| $1.04M | ﹤0.01% |
240,828
-4,062
| -2% | -$12.5K |
|
1785
FuelCell Energy
FCEL
$1.6B
| $1.04M | ﹤0.01% |
12,467
+159
| +1% | +$15.3K |
|
1786
The Greenbrier Companies
GBX
$1.42B
| $1.04M | ﹤0.01% |
30,958
+1,906
| +7% | +$63.5K |
|
1787
FB Financial Corp
FBK
$3.03B
| $1.03M | ﹤0.01% |
28,563
| – | – |
|
|
VVNT
1788
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $1.03M | ﹤0.01% |
86,596
+6,097
| +8% | +$54.9K |
|
1789
Digi International
DGII
$3.17B
| $1.03M | ﹤0.01% |
28,150
+1,292
| +5% | +$49.7K |
|
1790
Federal Agricultural Mortgage
AGM
$2.54B
| $1.03M | ﹤0.01% |
9,119
+1,402
| +18% | +$161K |
|
|
FBRT
1791
Franklin BSP Realty Trust
FBRT
$640M
| $1.03M | ﹤0.01% |
79,669
+40,048
| +101% | +$536K |
|
1792
Columbia Financial
CLBK
$1.13B
| $1.02M | ﹤0.01% |
47,367
| – | – |
|
1793
Fortis
FTS
$28.3B
| $1.02M | ﹤0.01% |
25,532
+1,410
| +6% | +$55.3K |
|
1794
Novavax
NVAX
$1.29B
| $1.02M | ﹤0.01% |
99,432
+348
| +0.4% | +$6.14K |
|
|
TSE
1795
DELISTED
Trinseo
TSE
| $1.02M | ﹤0.01% |
44,982
+2,267
| +5% | +$50K |
|
1796
Stem
STEM
$48.2M
| $1.02M | ﹤0.01% |
5,713
+946
| +20% | +$227K |
|
1797
ACV Auctions
ACVA
$1.25B
| $1.02M | ﹤0.01% |
124,343
+12,492
| +11% | +$104K |
|
1798
Hims & Hers Health
HIMS
$7.32B
| $1.02M | ﹤0.01% |
159,079
+53,081
| +50% | +$302K |
|
1799
Rocket Companies
RKT
$38.6B
| $1.01M | ﹤0.01% |
144,580
-28,200
| -16% | -$206K |
|
|
ZUO
1800
DELISTED
Zuora, Inc.
ZUO
| $1.01M | ﹤0.01% |
158,594
+18,874
| +14% | +$133K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.